Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             230 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations Aidoo, Michael
2007
25 Supplement 1 p. 6474-6481
8 p.
artikel
2 A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan Nagai, Takao
2007
25 Supplement 1 p. 2742-2747
6 p.
artikel
3 Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants Sokolovska, Anna
2007
25 Supplement 1 p. 4575-4585
11 p.
artikel
4 Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP–IPV–PRP∼T–HBs) combination vaccine Stojanov, S.
2007
25 Supplement 1 p. 7549-7558
10 p.
artikel
5 A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination Cassataro, Juliana
2007
25 Supplement 1 p. 5958-5967
10 p.
artikel
6 Advances in Immunology and Vaccine Discovery Gay, Cyril G.
2007
25 Supplement 1 p. 7007-7011
5 p.
artikel
7 Advances in methods for the production, purification, and characterization of HIV-1 Gag–Env pseudovirion vaccines Hammonds, Jason
2007
25 Supplement 1 p. 8036-8048
13 p.
artikel
8 A dynamic model for assessing universal Hepatitis A vaccination in Canada Bauch, C.T.
2007
25 Supplement 1 p. 1719-1726
8 p.
artikel
9 Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005 Ceyhan, Mehmet
2007
25 Supplement 1 p. 7233-7237
5 p.
artikel
10 A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions Rourou, Samia
2007
25 Supplement 1 p. 3879-3889
11 p.
artikel
11 Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains Tano, Yoshio
2007
25 Supplement 1 p. 7041-7046
6 p.
artikel
12 Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: Implications for vaccine development Yuen, Don
2007
25 Supplement 1 p. 490-499
10 p.
artikel
13 A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11 Slupetzky, Katharina
2007
25 Supplement 1 p. 2001-2010
10 p.
artikel
14 A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults Kester, Kent E.
2007
25 Supplement 1 p. 5359-5366
8 p.
artikel
15 A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination Cassataro, Juliana
2007
25 Supplement 1 p. 4437-4446
10 p.
artikel
16 A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells Marzio, G.
2007
25 Supplement 1 p. 2228-2237
10 p.
artikel
17 A sensitive cell-based assay for the detection of residual infectious West Nile virus Koldijk, M.H.
2007
25 Supplement 1 p. 6872-6881
10 p.
artikel
18 A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months Tsang, Cemaine
2007
25 Supplement 1 p. 5485-5494
10 p.
artikel
19 Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis García-Yoldi, David
2007
25 Supplement 1 p. 2858-2862
5 p.
artikel
20 Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells Rabablert, Jundee
2007
25 Supplement 1 p. 3896-3905
10 p.
artikel
21 Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge Bråve, Andreas
2007
25 Supplement 1 p. 6882-6890
9 p.
artikel
22 Caprine herpesvirus 1 vaccine with the LTK63 mutant as a mucosal adjuvant induces strong protection against genital infection in goats Tempesta, M.
2007
25 Supplement 1 p. 7927-7930
4 p.
artikel
23 Cattle immune response to botulinum type D toxoid: Results of a vaccination study Steinman, A.
2007
25 Supplement 1 p. 7636-7640
5 p.
artikel
24 Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses Kistner, Otfried
2007
25 Supplement 1 p. 6028-6036
9 p.
artikel
25 Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: A 16-year study Torzillo, Paul J.
2007
25 Supplement 1 p. 2375-2378
4 p.
artikel
26 Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid Silveira, I.A.F.B.
2007
25 Supplement 1 p. 7261-7270
10 p.
artikel
27 Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine Gruener, Norbert H.
2007
25 Supplement 1 p. 4960-4966
7 p.
artikel
28 Characterization of the antibody response elicited by HIV-1 Env glycomutants in rabbits Reynard, F.
2007
25 Supplement 1 p. 535-546
12 p.
artikel
29 Chemokine and cytokine gene expression profiles in chickens inoculated with Mycoplasma gallisepticum strains R low or GT5 Mohammed, Javed
2007
25 Supplement 1 p. 8611-8621
11 p.
artikel
30 Chitosan solution enhances the immunoadjuvant properties of GM-CSF Zaharoff, David A.
2007
25 Supplement 1 p. 8673-8686
14 p.
artikel
31 Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine Karpenko, Larisa I.
2007
25 Supplement 1 p. 4312-4323
12 p.
artikel
32 Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques Chong, Siew-Yen
2007
25 Supplement 1 p. 4967-4982
16 p.
artikel
33 Comparative efficacy of an indigenous ‘inactivated vaccine’ using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis ‘Bison type’ with a commercial vaccine for the control of Capri-paratuberculosis in India Singh, S.V.
2007
25 Supplement 1 p. 7102-7110
9 p.
artikel
34 Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines Wan, Yanmin
2007
25 Supplement 1 p. 4949-4959
11 p.
artikel
35 Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: Otitis media and acute pneumonia Cripps, Allan W.
2007
25 Supplement 1 p. 2471-2477
7 p.
artikel
36 Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine Álvarez, M.
2007
25 Supplement 1 p. 6613-6617
5 p.
artikel
37 Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation Liang, Rong
2007
25 Supplement 1 p. 5994-6006
13 p.
artikel
38 Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic Malhotra, Uma
2007
25 Supplement 1 p. 381-390
10 p.
artikel
39 Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: A strategy for enhancing immunogenicity of malaria vaccine candidates Qian, Feng
2007
25 Supplement 1 p. 3923-3933
11 p.
artikel
40 Construction and evaluation of a multistage combination vaccine against malaria Zhang, Qingfeng
2007
25 Supplement 1 p. 2112-2119
8 p.
artikel
41 Construction and immunogenicity of recombinant adenovirus expressing the major outer membrane protein (MOMP) of Chlamydophila psittaci in chicks Zhou, Jizhang
2007
25 Supplement 1 p. 6367-6372
6 p.
artikel
42 Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli Roland, Kenneth L.
2007
25 Supplement 1 p. 8574-8584
11 p.
artikel
43 Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: Preclinical evidence of immunogenicity and protection Xu, De Qi
2007
25 Supplement 1 p. 6167-6175
9 p.
artikel
44 Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3–14 years from the provider and societal perspectives Navas, E.
2007
25 Supplement 1 p. 3233-3239
7 p.
artikel
45 Countries 2007
25 Supplement 1 p. C27-C219
nvt p.
artikel
46 Cytokine gene expression patterns associated with immunization against Marek's disease in chickens Abdul-Careem, Mohamed Faizal
2007
25 Supplement 1 p. 424-432
9 p.
artikel
47 Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle Toussaint, J.F.
2007
25 Supplement 1 p. 1167-1174
8 p.
artikel
48 Dermal testing of vaccines for children at high risk of allergies Sugai, Kazuko
2007
25 Supplement 1 p. 3454-3463
10 p.
artikel
49 Design and characterization of an HIV-1 Tat mutant: Inactivation of viral and cellular functions but not antigenicity Mayol, Katia
2007
25 Supplement 1 p. 6047-6060
14 p.
artikel
50 Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people Boot, Hein J.
2007
25 Supplement 1 p. 4706-4714
9 p.
artikel
51 Developing an HPV vaccine to prevent cervical cancer and genital warts Bryan, Janine T.
2007
25 Supplement 1 p. 3001-3006
6 p.
artikel
52 Development and registration of recombinant veterinary vaccines Poulet, Hervé
2007
25 Supplement 1 p. 5606-5612
7 p.
artikel
53 Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection Thorpe, Callum
2007
25 Supplement 1 p. 2252-2260
9 p.
artikel
54 DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity Buonaguro, L.
2007
25 Supplement 1 p. 5968-5977
10 p.
artikel
55 Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost Liu, Jinyan
2007
25 Supplement 1 p. 2951-2958
8 p.
artikel
56 Dose–response to type V group B streptococcal polysaccharide–tetanus toxoid conjugate vaccine in healthy adults Baker, Carol J.
2007
25 Supplement 1 p. 55-63
9 p.
artikel
57 Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers Goepfert, Paul A.
2007
25 Supplement 1 p. 510-518
9 p.
artikel
58 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
59 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
60 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
61 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
62 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
63 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
64 Editorial Board 2007
25 Supplement 1 p. CO2-
1 p.
artikel
65 Editorial Board/Aims and Scope 2007
25 Supplement 1 p. CO2-
1 p.
artikel
66 Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens Uddowla, Sabena
2007
25 Supplement 1 p. 7984-7993
10 p.
artikel
67 Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine Zhang, Xiaofei
2007
25 Supplement 1 p. 3254-3262
9 p.
artikel
68 Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag Santos, Kathlyn
2007
25 Supplement 1 p. 1634-1646
13 p.
artikel
69 Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis Watts, Douglas M.
2007
25 Supplement 1 p. 2913-2918
6 p.
artikel
70 Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs Shu, Yuuei
2007
25 Supplement 1 p. 1398-1408
11 p.
artikel
71 Epidemiology of invasive Haemophilus influenzae type b disease in Singapore children, 1994–2003 Thoon, Koh Cheng
2007
25 Supplement 1 p. 6482-6489
8 p.
artikel
72 Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave® Bioreactor microcarrier culture in 1–10L scale Hundt, B.
2007
25 Supplement 1 p. 3987-3995
9 p.
artikel
73 Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005–2006 season of dual A and B vaccine mismatch in Canada Skowronski, D.M.
2007
25 Supplement 1 p. 2842-2851
10 p.
artikel
74 Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice Song, Shuxia
2007
25 Supplement 1 p. 4853-4860
8 p.
artikel
75 Evaluation of combinatorial vaccines against anthrax and plague in a murine model DuBois, Amanda B.
2007
25 Supplement 1 p. 4747-4754
8 p.
artikel
76 Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model Rollman, Erik
2007
25 Supplement 1 p. 2145-2154
10 p.
artikel
77 Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy Rossi, Renato E.
2007
25 Supplement 1 p. 957-964
8 p.
artikel
78 Expression library immunization confers partial protection against Chlamydia muridarum genital infection McNeilly, Celia L.
2007
25 Supplement 1 p. 2643-2655
13 p.
artikel
79 Factors influencing the antibody response of dogs vaccinated against rabies Kennedy, Lorna J.
2007
25 Supplement 1 p. 8500-8507
8 p.
artikel
80 FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice Luo, Yunping
2007
25 Supplement 1 p. 1409-1415
7 p.
artikel
81 Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs Orsel, K.
2007
25 Supplement 1 p. 6381-6391
11 p.
artikel
82 Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin Lagergård, Teresa
2007
25 Supplement 1 p. 3606-3614
9 p.
artikel
83 Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits Guillon, Christophe
2007
25 Supplement 1 p. 7491-7501
11 p.
artikel
84 Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C Gómez, Carmen Elena
2007
25 Supplement 1 p. 1969-1992
24 p.
artikel
85 Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children Heeg, Christiane
2007
25 Supplement 1 p. 1030-1035
6 p.
artikel
86 Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus de Souza, Ana Paula D.
2007
25 Supplement 1 p. 109-116
8 p.
artikel
87 Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice Yang, Zhigang
2007
25 Supplement 1 p. 161-169
9 p.
artikel
88 Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial Hermsen, Cornelus C.
2007
25 Supplement 1 p. 2930-2940
11 p.
artikel
89 GTU®-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model Malm, Maria
2007
25 Supplement 1 p. 3293-3301
9 p.
artikel
90 Guillain–Barre syndrome after vaccination in United States Souayah, Nizar
2007
25 Supplement 1 p. 5253-5255
3 p.
artikel
91 Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B Gómez, Carmen Elena
2007
25 Supplement 1 p. 2863-2885
23 p.
artikel
92 Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years Hammitt, Laura L.
2007
25 Supplement 1 p. 6958-6964
7 p.
artikel
93 Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies Stamataki, Zania
2007
25 Supplement 1 p. 7773-7784
12 p.
artikel
94 Herd immunity and pneumococcal conjugate vaccine: A quantitative model Haber, Michael
2007
25 Supplement 1 p. 5390-5398
9 p.
artikel
95 High immunogenicity of delayed third dose of hepatitis B vaccine in travellers Jackson, Yves
2007
25 Supplement 1 p. 3482-3484
3 p.
artikel
96 HIV-189.6 Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice Parker, Scott D.
2007
25 Supplement 1 p. 6764-6773
10 p.
artikel
97 Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan Chen, Kow-Tong
2007
25 Supplement 1 p. 4266-4272
7 p.
artikel
98 HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime Duke, Cindy M.P.
2007
25 Supplement 1 p. 7410-7421
12 p.
artikel
99 Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection Linder, Adam
2007
25 Supplement 1 p. 341-345
5 p.
artikel
100 Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine Barreto, L.
2007
25 Supplement 1 p. 8172-8179
8 p.
artikel
101 Identification of pentadecapeptide mimicking muramyl peptide Laman, Alexander Georgievich
2007
25 Supplement 1 p. 2900-2906
7 p.
artikel
102 Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus Li, Yun-Gang
2007
25 Supplement 1 p. 902-911
10 p.
artikel
103 Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis Moreno, J.
2007
25 Supplement 1 p. 5290-5300
11 p.
artikel
104 Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling Cai, Qiliang
2007
25 Supplement 1 p. 5155-5165
11 p.
artikel
105 Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium Costa, Wagner A.
2007
25 Supplement 1 p. 8140-8145
6 p.
artikel
106 Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients Loutan, L.
2007
25 Supplement 1 p. 6310-6312
3 p.
artikel
107 Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006) Oosterhuis-Kafeja, Froukje
2007
25 Supplement 1 p. 2194-2212
19 p.
artikel
108 Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs van den Dobbelsteen, Germie P.J.M.
2007
25 Supplement 1 p. 2491-2496
6 p.
artikel
109 Immunogenicity of a subunit vaccine against Bacillus anthracis Chichester, Jessica A.
2007
25 Supplement 1 p. 3111-3114
4 p.
artikel
110 Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice Deshmukh, Tejaswini M.
2007
25 Supplement 1 p. 4350-4360
11 p.
artikel
111 Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice Devi, Yengkhom Sangeeta
2007
25 Supplement 1 p. 5166-5174
9 p.
artikel
112 Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state Kim, Mikyung
2007
25 Supplement 1 p. 5102-5114
13 p.
artikel
113 Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Jackson, Lisa A.
2007
25 Supplement 1 p. 4029-4037
9 p.
artikel
114 Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins Quan, Fu-Shi
2007
25 Supplement 1 p. 3841-3850
10 p.
artikel
115 Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: A randomised controlled trial Heron, Leon
2007
25 Supplement 1 p. 2817-2822
6 p.
artikel
116 Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants Esposito, Susanna
2007
25 Supplement 1 p. 4889-4894
6 p.
artikel
117 Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1 Fischer, Geferson
2007
25 Supplement 1 p. 1250-1256
7 p.
artikel
118 Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate Cano, Jean Paul
2007
25 Supplement 1 p. 4382-4391
10 p.
artikel
119 Impact of variation in acute virulence of BVDV1 strains on design of better vaccine efficacy challenge models Ridpath, Julia F.
2007
25 Supplement 1 p. 8058-8066
9 p.
artikel
120 Implementation of good clinical practice guidelines in vaccine trials in developing countries Acosta, Camilo J.
2007
25 Supplement 1 p. 2852-2857
6 p.
artikel
121 Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity Carra, John H.
2007
25 Supplement 1 p. 4149-4158
10 p.
artikel
122 Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870 Koeberling, Oliver
2007
25 Supplement 1 p. 1912-1920
9 p.
artikel
123 IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study Brignone, Chrystelle
2007
25 Supplement 1 p. 4641-4650
10 p.
artikel
124 Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans Eller, Michael A.
2007
25 Supplement 1 p. 7737-7742
6 p.
artikel
125 Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine Calarota, Sandra A.
2007
25 Supplement 1 p. 3070-3074
5 p.
artikel
126 Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine Olsson, Sven-Eric
2007
25 Supplement 1 p. 4931-4939
9 p.
artikel
127 Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases Shi, Frank F.
2007
25 Supplement 1 p. 3338-3346
9 p.
artikel
128 Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut Lin, S.W.
2007
25 Supplement 1 p. 2187-2193
7 p.
artikel
129 Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection Cong, Yu
2007
25 Supplement 1 p. 3773-3780
8 p.
artikel
130 Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection Manuri, Pallavi R.
2007
25 Supplement 1 p. 3302-3310
9 p.
artikel
131 Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge Munro, Patrick
2007
25 Supplement 1 p. 8702-8706
5 p.
artikel
132 Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats Camero, Michele
2007
25 Supplement 1 p. 1658-1661
4 p.
artikel
133 Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy Puthanakit, Thanyawee
2007
25 Supplement 1 p. 8257-8261
5 p.
artikel
134 Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis Hwang, Shen-An
2007
25 Supplement 1 p. 6730-6743
14 p.
artikel
135 LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains Zhu, C.
2007
25 Supplement 1 p. 1884-1892
9 p.
artikel
136 Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys Jiang, Shisong
2007
25 Supplement 1 p. 7470-7479
10 p.
artikel
137 Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine Asanuma, Hideki
2007
25 Supplement 1 p. 6975-6980
6 p.
artikel
138 Long-term colonisation–inhibition studies to protect broilers against colonisation with Salmonella Enteritidis, using Salmonella Pathogenicity Island 1 and 2 mutants Bohez, Lotte
2007
25 Supplement 1 p. 4235-4243
9 p.
artikel
139 Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma Zuccotti, Gianvincenzo
2007
25 Supplement 1 p. 6692-6698
7 p.
artikel
140 Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents Gabbuti, Andrea
2007
25 Supplement 1 p. 3129-3132
4 p.
artikel
141 Major CD4 epitopes involved in anti-CD4 T-cell autoimmunity in HIV-1 patients Abulafia-Lapid, Rivka
2007
25 Supplement 1 p. 3192-3199
8 p.
artikel
142 Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins Cavanagh, Dave
2007
25 Supplement 1 p. 5558-5562
5 p.
artikel
143 Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle Abdul-Wahid, Aws
2007
25 Supplement 1 p. 8372-8383
12 p.
artikel
144 Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice Ellis, John A.
2007
25 Supplement 1 p. 1085-1095
11 p.
artikel
145 Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses Huang, Xianggang
2007
25 Supplement 1 p. 2620-2629
10 p.
artikel
146 Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses Huang, Xianggang
2007
25 Supplement 1 p. 8874-8884
11 p.
artikel
147 Mycobacterium bovis BCG as a delivery system for the RAP-1 antigen from Babesia bovis Santangelo, M.P.
2007
25 Supplement 1 p. 1104-1113
10 p.
artikel
148 New assays to measure equine influenza virus-specific Type 1 immunity in horses Paillot, R.
2007
25 Supplement 1 p. 7385-7398
14 p.
artikel
149 Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag Qiu, Jian-Tai
2007
25 Supplement 1 p. 253-263
11 p.
artikel
150 Novel marker vaccines against classical swine fever Beer, Martin
2007
25 Supplement 1 p. 5665-5670
6 p.
artikel
151 Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines Michel, Marie
2007
25 Supplement 1 p. 1901-1911
11 p.
artikel
152 Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules Mercier, George T.
2007
25 Supplement 1 p. 8687-8701
15 p.
artikel
153 Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity Cross, M.L.
2007
25 Supplement 1 p. 1297-1303
7 p.
artikel
154 Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention Esposito, Susanna
2007
25 Supplement 1 p. 6437-6446
10 p.
artikel
155 Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population Rendi-Wagner, Pamela
2007
25 Supplement 1 p. 927-931
5 p.
artikel
156 Pertussis vaccine and infantile spasms Lapatsanis, Petros
2007
25 Supplement 1 p. 404-405
2 p.
artikel
157 Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults Halperin, Scott A.
2007
25 Supplement 1 p. 450-457
8 p.
artikel
158 Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine Catanzaro, Andrew T.
2007
25 Supplement 1 p. 4085-4092
8 p.
artikel
159 Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research Polhemus, Mark E.
2007
25 Supplement 1 p. 4203-4212
10 p.
artikel
160 Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya Stoute, José A.
2007
25 Supplement 1 p. 176-184
9 p.
artikel
161 Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults Scott, Daniel A.
2007
25 Supplement 1 p. 6164-6166
3 p.
artikel
162 Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes Hui, George
2007
25 Supplement 1 p. 948-956
9 p.
artikel
163 Populations of pharyngeal meningococci in Niger Nicolas, Pierre
2007
25 Supplement 1 p. A53-A57
nvt p.
artikel
164 Potential use an Actinobacillus pleuropneumoniae double mutant strain ΔapxIICΔapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals Liu, Jinlin
2007
25 Supplement 1 p. 7696-7705
10 p.
artikel
165 Preparation and immunogenic properties of a recombinant West Nile subunit vaccine Lieberman, Michael M.
2007
25 Supplement 1 p. 414-423
10 p.
artikel
166 Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection Pancré, Véronique
2007
25 Supplement 1 p. 5927-5937
11 p.
artikel
167 Prevenar™ vaccination: Review of the global data, 2006 Center, Kimberly J.
2007
25 Supplement 1 p. 3085-3089
5 p.
artikel
168 Prime-boost immunization with DNA, recombinant fowlpox virus and VLPSHIV elicit both neutralizing antibodies and IFNγ-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells Radaelli, Antonia
2007
25 Supplement 1 p. 2128-2138
11 p.
artikel
169 Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease Hsieh, Ming Kun
2007
25 Supplement 1 p. 5417-5427
11 p.
artikel
170 Private demand for cholera vaccines in Beira, Mozambique Lucas, Marcelino E.S.
2007
25 Supplement 1 p. 2599-2609
11 p.
artikel
171 Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine Greco, Raffaella
2007
25 Supplement 1 p. 8228-8240
13 p.
artikel
172 Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus Quinlivan, Michelle
2007
25 Supplement 1 p. 7056-7064
9 p.
artikel
173 Prophylactic DNA immunization against multiple papillomavirus types Gašparić, Maja
2007
25 Supplement 1 p. 4540-4553
14 p.
artikel
174 Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain Martelli, Paolo
2007
25 Supplement 1 p. 3400-3408
9 p.
artikel
175 Protective efficacy of neutralizing antibodies against Ebola virus infection Takada, Ayato
2007
25 Supplement 1 p. 993-999
7 p.
artikel
176 Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays Skovsted, Ian Chr.
2007
25 Supplement 1 p. 6490-6500
11 p.
artikel
177 Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine Smets, F.
2007
25 Supplement 1 p. 5278-5282
5 p.
artikel
178 Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program 2007
25 Supplement 1 p. 3118-3123
6 p.
artikel
179 Rates of contraindications and use of alternative vaccines in routine immunisation of children: A population based study in the Czech Republic Danova, Jana
2007
25 Supplement 1 p. 3890-3895
6 p.
artikel
180 Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model Du, Lanying
2007
25 Supplement 1 p. 2832-2838
7 p.
artikel
181 Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B Zhan, Xiaoyan
2007
25 Supplement 1 p. 8782-8793
12 p.
artikel
182 Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development Patel, Janak A.
2007
25 Supplement 1 p. 1683-1689
7 p.
artikel
183 Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults Macaladad, N.
2007
25 Supplement 1 p. 2139-2144
6 p.
artikel
184 Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa Sirima, Sodiomon B.
2007
25 Supplement 1 p. 2723-2732
10 p.
artikel
185 Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy Dorrell, Lucy
2007
25 Supplement 1 p. 3277-3283
7 p.
artikel
186 Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults Kshirsagar, Nilima
2007
25 Supplement 1 p. A101-A107
nvt p.
artikel
187 Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine Partridge, Susan
2007
25 Supplement 1 p. 1806-1813
8 p.
artikel
188 Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia Aseffa, Abraham
2007
25 Supplement 1 p. A79-A82
nvt p.
artikel
189 Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease Nøkleby, H.
2007
25 Supplement 1 p. 3080-3084
5 p.
artikel
190 SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus Kitabatake, Masahiro
2007
25 Supplement 1 p. 630-637
8 p.
artikel
191 Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan Liu, Ching-Yun
2007
25 Supplement 1 p. 7706-7710
5 p.
artikel
192 Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago Wang, Li-Yu
2007
25 Supplement 1 p. 7160-7167
8 p.
artikel
193 Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus Barabé, Nicole D.
2007
25 Supplement 1 p. 6271-6276
6 p.
artikel
194 Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity Peters, Barry S.
2007
25 Supplement 1 p. 2120-2127
8 p.
artikel
195 Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit–insulin B chain fusion protein vaccine produced in silkworm Gong, Zhaohui
2007
25 Supplement 1 p. 1444-1451
8 p.
artikel
196 Surface simulation synthesis: A new strategy to spy α-helix structure Dong, Xiao-Nan
2007
25 Supplement 1 p. 6569-6571
3 p.
artikel
197 Survey of poliovirus antibodies during the final stage of polio eradication in Egypt El-Sayed, Nasr
2007
25 Supplement 1 p. 5062-5070
9 p.
artikel
198 Sustained measles elimination in Australia and priorities for long term maintenance Gidding, Heather F.
2007
25 Supplement 1 p. 3574-3580
7 p.
artikel
199 Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice Sharon, Melamed
2007
25 Supplement 1 p. 7743-7753
11 p.
artikel
200 Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties Campbell, Grant R.
2007
25 Supplement 1 p. 8441-8447
7 p.
artikel
201 The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys Rojas Caraballo, Jose
2007
25 Supplement 1 p. 3713-3721
9 p.
artikel
202 The clinical grade maturation cocktail monophosphoryl lipid A plus IFNγ generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization ten Brinke, Anja
2007
25 Supplement 1 p. 7145-7152
8 p.
artikel
203 The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection Kojima, Yoshitsugu
2007
25 Supplement 1 p. 438-445
8 p.
artikel
204 The effect of vaccination on foot and mouth disease virus transmission among dairy cows Orsel, K.
2007
25 Supplement 1 p. 327-335
9 p.
artikel
205 The epidemiology and burden of rotavirus in China: A review of the literature from 1983 to 2005 Orenstein, Evan W.
2007
25 Supplement 1 p. 406-413
8 p.
artikel
206 The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents Ortega-Barrìa, Eduardo
2007
25 Supplement 1 p. 8432-8440
9 p.
artikel
207 The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia Gidding, Heather F.
2007
25 Supplement 1 p. 8637-8641
5 p.
artikel
208 The Meningitis Vaccine Project LaForce, F. Marc
2007
25 Supplement 1 p. A97-A100
nvt p.
artikel
209 The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity Park, Mi-Young
2007
25 Supplement 1 p. 7322-7330
9 p.
artikel
210 The preventable burden of pneumococcal disease in the developing world Scott, J.A.G.
2007
25 Supplement 1 p. 2398-2405
8 p.
artikel
211 Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours Chandy, Annie George
2007
25 Supplement 1 p. 6037-6046
10 p.
artikel
212 The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine Hui, George
2007
25 Supplement 1 p. 8549-8556
8 p.
artikel
213 The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease Hausdorff, William P.
2007
25 Supplement 1 p. 2406-2412
7 p.
artikel
214 Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control Hamaguchi, Isao
2007
25 Supplement 1 p. 3355-3364
10 p.
artikel
215 Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses Bublin, Merima
2007
25 Supplement 1 p. 8395-8404
10 p.
artikel
216 Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice Lee, Seung Ihm
2007
25 Supplement 1 p. 7047-7055
9 p.
artikel
217 Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis De Wals, Philippe
2007
25 Supplement 1 p. 5433-5440
8 p.
artikel
218 Vaccination associated thrombocytopenic purpura in children Rajantie, J.
2007
25 Supplement 1 p. 1838-1840
3 p.
artikel
219 Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus Odongo, David
2007
25 Supplement 1 p. 1287-1296
10 p.
artikel
220 Vaccination of chickens against Campylobacter de Zoete, Marcel R.
2007
25 Supplement 1 p. 5548-5557
10 p.
artikel
221 Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín Palmer, M.V.
2007
25 Supplement 1 p. 6589-6597
9 p.
artikel
222 Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3 Saini, Manisha
2007
25 Supplement 1 p. 8660-8663
4 p.
artikel
223 Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi Timoney, John F.
2007
25 Supplement 1 p. 5583-5590
8 p.
artikel
224 Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients Skull, Susan A.
2007
25 Supplement 1 p. 4775-4783
9 p.
artikel
225 Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses Fine, Donald L.
2007
25 Supplement 1 p. 1868-1876
9 p.
artikel
226 Viral antigen production in cell cultures on microcarriers Conceição, M.M.
2007
25 Supplement 1 p. 7785-7795
11 p.
artikel
227 What needs to be done for polio eradication in India? Paul, Yash
2007
25 Supplement 1 p. 6431-6436
6 p.
artikel
228 WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1–2 June 2006 Ferguson, Morag
2007
25 Supplement 1 p. 5233-5243
11 p.
artikel
229 Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins Haller, Aurelia A.
2007
25 Supplement 1 p. 1452-1463
12 p.
artikel
230 Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994–2000) Hawker, Jeremy I.
2007
25 Supplement 1 p. 7516-7519
4 p.
artikel
                             230 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland